The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.
about
Nuclear β-Catenin Expression is Frequent in Sinonasal Hemangiopericytoma and Its Mimics.Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay.Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors.Therapeutic applications of histone deacetylase inhibitors in sarcoma.
P2860
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The fusion protein SS18-SSX1 e ...... signature in synovial sarcoma.
@en
type
label
The fusion protein SS18-SSX1 e ...... signature in synovial sarcoma.
@en
prefLabel
The fusion protein SS18-SSX1 e ...... signature in synovial sarcoma.
@en
P2093
P2860
P356
P1433
P1476
The fusion protein SS18-SSX1 e ...... signature in synovial sarcoma.
@en
P2093
Carlo Fusco
Giulia Fregni
Igor Letovanec
Ivan Stamenkovic
Luisa Cironi
Michel Aguet
Paolo Provero
Sandrine Cornaz
Tanja Petricevic
Victor Fernandes Vieira
P2860
P2888
P356
10.1038/SREP22113
P407
P577
2016-02-24T00:00:00Z
P5875
P6179
1026955153